The landscape of the North American cannabis industry just shifted dramatically.
On December 15, 2025, President Donald Trump confirmed that the White House is “very strongly” considering an executive order to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act.
Advised by key figures including HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, this move would recognize cannabis’s accepted medical uses and align it with substances like ketamine, removing it from the same restrictive category as heroin.
While the political implications are vast, the business implications are immediate. For manufacturers, stockists, and dispensaries, this signals the start of a massive inventory ramp-up leading into 2026.
The segment poised to benefit most? Pre-rolled cones.
Here is the data-driven case for why 2026 will be the year of the pre-roll boom, and how supply chains must prepare now.
The Pre-Roll Dominance (The Current Landscape)
Even before this historic announcement, pre-rolls were established as the industry’s hottest category. Driven by consumer demand for convenience and affordable luxury, pre-rolls have outpaced flower and edibles in growth velocity.
FACTSHEET: The 2025 Pre-Roll Powerhouse
Surging Sales: Pre-roll sales hit $4.1 billion across 394 million units sold between June 2023 and June 2024.
Year-over-Year Growth: The category experienced an 11.89% sales surge during that period.
Infused is King: Infused pre-rolls alone accounted for $1.75 billion, driven by demand for higher potency and premium quality.
Global Trajectory: The global pre-rolled cones market was valued at $297.61 million in 2023 and is projected to hit $1.107 billion by 2029 (a 24.49% CAGR).
The Catalyst: How Schedule III Rescheduling Fuels 2026
Moving to Schedule III is not just a symbolic victory; it is a financial unlock for the entire supply chain.
The most critical change is relief from IRS Section 280E. Currently, cannabis businesses cannot deduct standard business expenses, leading to effective tax rates upward of 70%. Rescheduling eliminates this burden.
FACTSHEET: The 2026 Rescheduling Boom Projections
Capital Injection: The elimination of 280E is estimated to free up $1 Billion+ in capital for operators nationwide.
Inventory Reinvestment: Analysts predict dispensaries will immediately redirect these tax savings into stockpiling high-turnover inventory—specifically pre-rolls—in Q1 2026.
Market Share Jump: Driven by new markets and federal research validation, pre-rolls are projected to grow from a 13.5% industry share to 20% by 2030.
CAGR Acceleration: The pre-roll sector is projected to grow at a 24.87% CAGR, reaching $2.77B by 2033.
The Supply Chain Squeeze: Why Bulk Stocking is Urgent
The demand is coming, but is the supply ready?
Pre-roll demand hinges on freshness and supply chain precision. Post-rescheduling, the market expects significant order surges in Q1 2026 as dispensaries rebuild inventories with their new tax savings.
However, international logistics mean that delays in production could cause severe shortages. Stockists without 3-6 months of bulk inventory on hand risk losing 20-30% market share to more agile competitors when the floodgates open.
Strategic Preparation for 2026:
Inventory Build: Secure 500K+ units pre-Q1 2026 to ensure readiness for dispensary restocking.
Leverage Cost Advantages: Partner with capable overseas OEMs. Facilities like NORML Cones‘ Gurugram plant serve 20+ North American brands with ISO standards, offering premium cones at 30-40% cost advantages versus domestic suppliers.
Supply Chain Automation: Invest now in rolling machinery to handle the surge in infused and multi-pack orders, which are overtaking single-strain sales.
The potential rescheduling of cannabis is the “starting gun” for the next phase of industry growth. The data shows that pre-rolled cones will lead this charge.
The $1 Billion+ capital infusion from tax relief will flow directly into inventory. The winners in 2026 will not be those who react to the news, but those who have already secured their supply lines to meet the demand.
Are your inventory levels ready for Q1 2026?
#CannabisNews #PreRolls #SupplyChain #MarijuanaRescheduling #CannabisIndustry #B2B #NORMLCones #MarketTrends2026